125 results
Page 2 of 7
S-8
mthzvjciv
30 Jun 22
Registration of securities for employees
4:05pm
S-8
EX-4.3
vnzmew4mgsc1
30 Jun 22
Registration of securities for employees
4:05pm
8-K
EX-10.1
f6p 6xo9ng3a9
24 Jun 22
Entry into a Material Definitive Agreement
5:23pm
8-K
s9so03o2r sq
24 Jun 22
Entry into a Material Definitive Agreement
5:23pm
DEFR14A
xaakkw n8p
12 May 22
Revised proxy
5:00pm
8-K
xqt smi6ol2gfv
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
EX-99.1
hbf8v
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
3wq56g
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
EX-99.1
dt3vny8
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
EX-14.1
3cvhii63jp
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
S-8
EX-23.1
khzwdvo
20 Oct 21
Registration of securities for employees
5:23pm
S-8
EX-4.1
b8bkp1n3n
20 Oct 21
Registration of securities for employees
5:23pm
S-8
mpu9uqo
20 Oct 21
Registration of securities for employees
5:23pm
8-K
cpz ehmgmfm
22 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm